Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
about
Catalytic enantioselective cyclization/cross-coupling with alkyl electrophiles.Indanes--Properties, Preparation, and Presence in Ligands for G Protein Coupled Receptors.Investigational insulin secretagogues for type 2 diabetes.GPR40 reduces food intake and body weight through GLP-1.Fasiglifam (TAK-875): Mechanistic Investigation and Retrospective Identification of Hazards for Drug Induced Liver Injury.Peripheral actions of GPCRs in energy homeostasis: view from the Chair.Virtual Systems Pharmacology (ViSP) software for simulation from mechanistic systems-level models.
P2860
Q37701007-5BC61F8E-3AE2-4B1D-8150-047CE4F6C64CQ38505134-09AD0B14-6639-4614-827D-8C525D3ABBD0Q38735419-510D7D45-6C7D-40D6-B1A8-83420CC451BFQ38908392-25EE5893-73F9-483F-8DF8-F4F6D99C32BDQ38958120-443773E4-FB20-4F00-BA3E-7E82916E2CF8Q39789645-CF931C42-4E4E-4041-930F-62D4496C34EFQ41788959-64FB4657-5342-4BDE-8E57-C222D162894E
P2860
Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
@en
type
label
Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
@en
prefLabel
Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
@en
P2860
P1476
Fasiglifam as a new potential treatment option for patients with type 2 diabetes.
@en
P2093
Kohei Kaku
P2860
P304
P356
10.1517/14656566.2013.851668
P407
P577
2013-11-06T00:00:00Z